These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15083479

  • 1. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML, Chinchilli VM.
    Stat Med; 2004 Apr 30; 23(8):1215-28. PubMed ID: 15083479
    [Abstract] [Full Text] [Related]

  • 2. A likelihood-based, counterfactual approach to accounting for treatment failures in clinical trials.
    Shaffer ML, Chinchilli VM.
    J Biopharm Stat; 2003 Aug 30; 13(3):481-94. PubMed ID: 12921395
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR, Berlin JA, Have TR.
    Stat Med; 2006 Aug 30; 25(16):2720-36. PubMed ID: 16345043
    [Abstract] [Full Text] [Related]

  • 4. Including multiple imputation in a sensitivity analysis for clinical trials with treatment failures.
    Shaffer ML, Chinchilli VM.
    Contemp Clin Trials; 2007 Feb 30; 28(2):130-7. PubMed ID: 16877049
    [Abstract] [Full Text] [Related]

  • 5. Discordant conclusions from HIV clinical trials--an evaluation of efficacy endpoints.
    Hill A, Demasi R.
    Antivir Ther; 2005 Feb 30; 10(3):367-74. PubMed ID: 15918328
    [Abstract] [Full Text] [Related]

  • 6. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ, Normand SL.
    Biometrics; 2005 Jun 30; 61(2):325-34. PubMed ID: 16011678
    [Abstract] [Full Text] [Related]

  • 7. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
    Kim MY, Xue X.
    J Clin Epidemiol; 2004 Dec 30; 57(12):1253-61. PubMed ID: 15617951
    [Abstract] [Full Text] [Related]

  • 8. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y, Little RJ, Raghunathan TE.
    Biometrics; 2004 Sep 30; 60(3):598-607. PubMed ID: 15339281
    [Abstract] [Full Text] [Related]

  • 9. Analysis of clinical data with breached blindness.
    Chow SC, Shao J.
    Stat Med; 2004 Apr 30; 23(8):1185-93. PubMed ID: 15083477
    [Abstract] [Full Text] [Related]

  • 10. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F, Friede T, Kieser M.
    Stat Med; 2009 May 30; 28(12):1690-706. PubMed ID: 19340815
    [Abstract] [Full Text] [Related]

  • 11. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR, Shahumyan H.
    Stat Med; 2007 Nov 30; 26(27):4939-57. PubMed ID: 17582801
    [Abstract] [Full Text] [Related]

  • 12. A Bayesian framework for intent-to-treat analysis with missing data.
    Kleinman KP, Ibrahim JG, Laird NM.
    Biometrics; 1998 Mar 30; 54(1):265-78. PubMed ID: 9544521
    [Abstract] [Full Text] [Related]

  • 13. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A.
    J Clin Epidemiol; 2009 Jan 30; 62(1):13-21.e5. PubMed ID: 18947971
    [Abstract] [Full Text] [Related]

  • 14. Bayesian interim analysis in clinical trials.
    Zhang X, Cutter G.
    Contemp Clin Trials; 2008 Sep 30; 29(5):751-5. PubMed ID: 18589003
    [Abstract] [Full Text] [Related]

  • 15. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D, Kim MY.
    Stat Med; 2006 Apr 15; 25(7):1183-99. PubMed ID: 16220491
    [Abstract] [Full Text] [Related]

  • 16. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S, Lanes S, Jara M.
    Clin Trials; 2008 Apr 15; 5(1):5-13. PubMed ID: 18283074
    [Abstract] [Full Text] [Related]

  • 17. Borrowing strength from external trials in a meta-analysis.
    Higgins JP, Whitehead A.
    Stat Med; 1996 Dec 30; 15(24):2733-49. PubMed ID: 8981683
    [Abstract] [Full Text] [Related]

  • 18. Randomization as a basis for inference in noninferiority trials.
    Wiens BL.
    Pharm Stat; 2006 Dec 30; 5(4):265-71. PubMed ID: 17128425
    [Abstract] [Full Text] [Related]

  • 19. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC.
    Depress Anxiety; 2009 Dec 30; 26(8):697-700. PubMed ID: 19658122
    [No Abstract] [Full Text] [Related]

  • 20. Bayesian evaluation of group sequential clinical trial designs.
    Emerson SS, Kittelson JM, Gillen DL.
    Stat Med; 2007 Mar 30; 26(7):1431-49. PubMed ID: 17066402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.